SHPMF (Shanghai Pharmaceuticals Holding Co) Scaled Net Operating Assets: 0.46 (As of Mar. 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.86
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Scaled Net Operating Assets?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 Scaled Net Operating Assets is 0.46 as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.86. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai Pharmaceuticals Holding Co's operating assets for the quarter that ended in Mar. 2026 was $28,185 Mil. Shanghai Pharmaceuticals Holding Co's operating liabilities for the quarter that ended in Mar. 2026 was $13,104 Mil. Shanghai Pharmaceuticals Holding Co's Total Assets for the quarter that ended in Dec. 2025 was $33,103 Mil. Therefore, Shanghai Pharmaceuticals Holding Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.46.


Shanghai Pharmaceuticals Holding Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Scaled Net Operating Assets Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.45 0.42 0.41 0.46

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.43 0.42 0.42 0.46

SHPMF vs MCK, CAH, COR: Scaled Net Operating Assets Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Scaled Net Operating Assets vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets falls into.


SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(26985.754-12930.884)/30382.989
=0.46

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=33102.676 - 6116.922
=26985.754

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=20354.594 - 764.603 - 6659.107
=12930.884

Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(28184.859-13103.644)/33102.676
=0.46

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=34150.619 - 5965.76
=28184.859

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=20879.262 - 684.813 - 7090.805
=13103.644

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.46 mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Scaled Net Operating Assets of 0.46 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets too high?
Shanghai Pharmaceuticals Holding Co's current Scaled Net Operating Assets is 0.46. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Scaled Net Operating Assets of 0.46 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Distribution company?
A good Scaled Net Operating Assets depends on the Medical Distribution industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Scaled Net Operating Assets is 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Scaled Net Operating Assets of 0.46. The stock's GF Value™ is $1.86, compared to a current price of $1.46 — trading 21.5% below its estimated fair value. The current Scaled Net Operating Assets is 0.46. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Scaled Net Operating Assets is 0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 21.5% below its estimated GF Value™ of $1.86.

Key valuation signals for SHPMF:

  • Scaled Net Operating Assets: 0.46
  • GF Value™: $1.86 vs. price of $1.46 (21.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.86
GF Value